Target intelligence / Profile preview

Synaptic structural plasticity pathways

Molecular classification
Other
01

Overview

Synaptic structural plasticity pathways refer to the complex molecular and cellular mechanisms that mediate physical changes in the shape, size, and number of neuronal connections, particularly dendritic spines. These pathways are fundamental to the brain's ability to encode information and adapt to environmental stimuli, serving as the structural basis for learning and memory (Source: Nature Reviews Neuroscience, 2018). Key components include the actin cytoskeleton, cell adhesion molecules, and signaling cascades triggered by neurotrophins like Brain-derived neurotrophic factor (BDNF) (Source: Frontiers in Molecular Neuroscience, 2021). Dysregulation of these pathways is strongly linked to the pathophysiology of neurodegenerative diseases like Alzheimer's and psychiatric disorders such as major depressive disorder and schizophrenia (Source: Molecular Psychiatry, 2019). Pharmacological intervention in these pathways, such as the use of ketamine or BDNF mimetics, aims to restore synaptic density and improve functional connectivity in the brain (Source: Science, 2019).

Other names
Structural plasticitySynaptic remodelingDendritic spine plasticitySynaptogenesis
02

Mechanism of action

Modulation of the actin cytoskeleton, activation of the TrkB/mTOR signaling pathway, and regulation of cell adhesion molecules to promote the formation and stabilization of dendritic spines.

03

Biological functions

Synaptic plasticityLearning and memoryNeuronal developmentSignal transductionCytoskeletal remodeling
04

Disease associations

Neurodegenerative diseaseAlzheimer's diseaseMajor depressive disorderSchizophreniaAutism spectrum disorderStroke recovery
05

Safety considerations

Risk of maladaptive plasticityPotential for seizure activityOff-target effects on non-neuronal cellsCognitive impairment from excessive remodeling
06

Interacting drugs

Ketamine

4 more in the full profile.

07

Biomarkers

SynaptophysinPostsynaptic density protein 95 (PSD-95)Brain-derived neurotrophic factor (BDNF)Growth associated protein 43 (GAP-43)

Beyond the preview

Go deeper on Synaptic structural plasticity pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptic structural plasticity pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call